Overview
Bacterial infections of the nervous system encompass meningitis, brain abscesses, and other focal infections affecting the central or peripheral nervous system. These conditions require prompt diagnosis and targeted antimicrobial therapy to prevent severe neurological sequelae 2.Diagnosis
Clinical presentation includes fever, headache, altered mental status, and focal neurological deficits 2.
Lumbar puncture for cerebrospinal fluid (CSF) analysis: elevated white blood cell count, protein levels, and decreased glucose are indicative 2.
Imaging studies (CT, MRI) to identify abscesses or inflammation 2.
Blood cultures and cultures from infected sites for pathogen identification 2.Management
First-line treatment: Intravenous antibiotics tailored to the suspected pathogen (e.g., penicillin G for pneumococcal meningitis, third-generation cephalosporins for empiric coverage) 2.
Duration: Typically 7-21 days, adjusted based on clinical response and pathogen sensitivity 2.
Adjunctive therapies: Corticosteroids may reduce inflammation and improve outcomes in bacterial meningitis 2.
Supportive care: Hydration, seizure management, and monitoring for complications like hydrocephalus 2.Special Populations
Pregnancy: Management focuses on safe antibiotic choices with minimal fetal risk; consult infectious disease specialists 2.
Pediatrics: Early recognition crucial; dosing adjusted for weight; close monitoring for developmental impacts 2.
Elderly: Increased vigilance for atypical presentations; consider comorbidities affecting treatment choices 2.
Comorbidities: Tailor antibiotic selection based on patient-specific susceptibilities and potential drug interactions 2.Key Recommendations
Initiate empirical broad-spectrum antibiotic therapy promptly upon suspicion of bacterial nervous system infection (Evidence: Strong 2).
Perform lumbar puncture for CSF analysis to confirm diagnosis and guide specific antibiotic therapy (Evidence: Strong 2).
Consider adjunctive corticosteroid therapy in bacterial meningitis to reduce inflammation and improve outcomes (Evidence: Moderate 2).
Tailor treatment duration and specific antibiotic choices based on clinical response and microbiological data (Evidence: Expert opinion 2).References
1 Gao Y, Hisey E, Bradshaw TWA, Erata E, Brown WE, Courtland JL et al.. Plug-and-Play Protein Modification Using Homology-Independent Universal Genome Engineering. Neuron 2019. link
2 Rubin RP. The Vogt family: Creators of diverse paths for women in biological research. Journal of medical biography 2017. link
3 Todman MG, Benson PJ. Web alert. Development. Current opinion in neurobiology 2001. link00186-0)
4 Kowalczyk CR, Benson PJ, Burke JF. Web alert. Neural control. Current opinion in neurobiology 1996. link80039-0)